Giant cell arteritis: early diagnosis is key
- PMID: 30697092
- PMCID: PMC6340646
- DOI: 10.2147/EB.S170388
Giant cell arteritis: early diagnosis is key
Abstract
Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease.
Keywords: giant cell arteritis; imaging in GCA; laboratory values in GCA; steroid-sparing agents in GCA; steroids in GCA.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures


References
-
- Hayreh SS, Zimmerman B. Management of giant cell arteritis. Ophthalmologica. 2003;217(4):239–259. - PubMed
-
- Rahman W, Rahman FZ, Cell G. Giant cell (temporal) arteritis: an overview and update. Surv Ophthalmol. 2005;50(5):415–428. - PubMed
-
- Hoffman GS, Arteritis GC. Giant cell arteritis. Ann Intern Med. 2016;165(9):ITC65. - PubMed
-
- El-Dairi MA, Chang L, Proia AD, Cummings TJ, Stinnett SS, Bhatti MT. Diagnostic algorithm for patients with suspected giant cell arteritis. J Neuroophthalmol. 2015;35(3):246–253. - PubMed
-
- Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261–271. - PubMed
Publication types
LinkOut - more resources
Full Text Sources